Niedrig dosiertes Naltrexon in der Behandlung dissoziativer Symptome
The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Abstract
Background Following the hypothesis that blocking opioid receptors leads to a decline in opiate-modulated dissociative phenomena, experiences with naltrexone as medication for dissociative symptoms have been gained since 1999 (mainly in doses of 25-100 mg/day). Patients and methods In this study patients with severe trauma-related and dissociative disorders were treated with naltrexone in doses of 2-6 mg/day (0.06 mg/kg body weight). Results The low dose treatment with naltrexone proved to be effective whereby 11 out of 15 patients reported immediate positive effects and 7 described a lasting helpful effect. The majority of patients who felt positive effects reported a clearer perception of both their surroundings and their inner life. Assessment of reality and dealing with it improved as did the perception of their own body and affects as well as self-regulation. The treatment was very low in side effects. Conclusion Treatment with low-dose naltrexone may be a helpful element in the treatment of patients with complex posttraumatic stress disorder. However, it has to be realized that the decrease of dissociation may lead patients to a not yet resolvable challenge, in as much as dissociation had previously been a necessary mechanism of self-protection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Are there two qualitatively distinct forms of dissociation? A review and some clinical implications
Holmes, E. A., Brown, R. J., Mansell, W., Fearon, R. P., Hunter, E. C. M., Frasquilho, F., & Oakley, D. A. (2005) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.08.006 · Cited by 619
Pitman, R. K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810180041007 · Cited by 296
Brand, B., Classen, C., Lanins, R., Loewenstein, R., McNary, S., Pain, C., & Putnam, F. (2009) · Psychological Trauma: Theory, Research, Practice, and Policy · doi:10.1037/a0016210 · Cited by 172
Bohus, M. J., Landwehrmeyer, G. B., Stiglmayr, C. E., Limberger, M. F., Böhme, R., & Schmahl, C. G. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0906 · Cited by 153
Borderline personality disorder: a dysregulation of the endogenous opioid system?
Bandelow, B., Schmahl, C., Falkai, P., & Wedekind, D. (2010) · Psychological Review · doi:10.1037/a0018095 · Cited by 135
Freyberger, H. J., Spitzer, C., Rd, S., Kuhn, G., Magdeburg, N., & Carlson, E. B. (1998) · PubMed · Cited by 114
An Open Trial of Naltrexone in the Treatment of Depersonalization Disorder
Simeon, D., & Knutelska, M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000162803.61700.4f · Cited by 80
Effect of naloxone therapy on depersonalization: a pilot study
Nuller, Y. L., Morozova, M. G., Kushnir, O. N., & Hamper, N. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500205 · Cited by 67
Bowirrat, A., J.H. Chen, T., Blum, K., Madigan, M., A. Bailey, J., Lih Chuan Chen, A., William Downs, B., R. Braverman, E., Radi, S., L. Waite, R., et al. (2010) · Current Neuropharmacology · doi:10.2174/157015910793358123 · Cited by 65
Evaluation of naltrexone for dissociative symptoms in borderline personality disorder
Schmahl, C., Kleindienst, N., Limberger, M., Ludäscher, P., Mauchnik, J., Deibler, P., Brünen, S., Hiemke, C., Lieb, K., Herpertz, S., et al. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32834d0e50 · Cited by 63
Neurobiology and Treatment of Traumatic Dissociation
Lanius, U. F., Paulsen, S. L., Corrigan, F. M., Lanius, U. F., Lanius, U. F., Paulsen, S. L., Corrigan, F. M., Corrigan, F. M., Bovin, M. J., Elise, R., et al. (2014) · Springer Publishing Company eBooks · doi:10.1891/9780826106322 · Cited by 59
Freyberger, H. J., Spitzer, C., Stieglitz, R., Kühn, G., Magdeburg, N., & Carlson, E. B. (1998) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · Cited by 47
Lubin, G., Weizman, A., Shmushkevitz, M., & Valevski, A. (2002) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.395 · Cited by 37
Brand, B. L., Classen, C. C., Lanius, R. A., Loewenstein, R. J., McNary, S. W., Pain, C., & Putnam, F. (2009) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/a0017060 · Cited by 10
Depersonalization: A history of depersonalization
Sierra, M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511730023.002 · Cited by 2
EMDR Processing with Dissociative Clients: Adjunctive Use of Opioid Antagonists.
Lanius, U. F. (2005) · Cited by 2
Cited by
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy
Li, Z., You, Y., Griffin, N., Feng, J., & Shan, F. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.05.020 · Cited by 87
Integrating NIMH Research Domain Criteria (RDoC) into PTSD Research
Schmidt, U., & Vermetten, E. H. G. J. M. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_1 · Cited by 52
Pharmacotherapy for dissociative disorders: A systematic review
Sutar, R., & Sahu, S. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112529 · Cited by 42
Possible role of a dysregulation of the endogenous opioid system in antisocial personality disorder
Bandelow, B., & Wedekind, D. (2015) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2497 · Cited by 41
Treatment of dissociative identity disorder: leveraging neurobiology to optimize success
Purcell, J. B., Brand, B., Browne, H. A., Chefetz, R. A., Shanahan, M., Bair, Z. A., Baranowski, K. A., Davis, V., Mangones, P., Modell, R. L., et al. (2024) · Expert review of neurotherapeutics · doi:10.1080/14737175.2024.2316153 · Cited by 18
Metadata
- Authors
- Pape, W., & Wöller, W.
- Corresponding author
- Pape, W.
- Venue
- Der Nervenarzt
- Published
- 2014-11-26
- Volume
- 86
- Issue
- 3
- Pages
- 346-351
- ISSN
- 0028-2804 (ISSN-L)
- 1433-0407
- OpenAlex
- W26162812
- Cited by
- 17
- References
- 18
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2019: 4 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 1
- FWCI
- 1.53
- Type
- journal article
- Language
- de
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Der Nervenarzt (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- naltrexone, low-dose naltrexone, dissociation, complex PTSD, opioid antagonism, self-regulation, reality testing
- MeSH terms
- Adult, Dissociative Disorders, Dose-Response Relationship, Drug, Drug Administration Schedule, Humans, Middle Aged, Naltrexone, Narcotic Antagonists, Stress Disorders, Post-Traumatic, Treatment Outcome, Patient Satisfaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.